What is Pulmonx Corporation's accrued liabilities, current?

Pulmonx Corporation (LUNG) reported accrued liabilities, current of $13.73M in Q1 2026.

How has Pulmonx Corporation's accrued liabilities, current changed year-over-year?

Pulmonx Corporation's accrued liabilities, current increased by 18.9% year-over-year, from $11.55M to $13.73M.

What is the long-term trend for Pulmonx Corporation's accrued liabilities, current?

Over 5 years (2020 to 2025), Pulmonx Corporation's accrued liabilities, current has grown at a 11.0% compound annual growth rate (CAGR), from $8.65M to $14.56M.

Pulmonx Corporation LUNG Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

SavaraSVRA

——

Viemed Healthcare, Inc.VMD

——

LivaNovaLIVN

——

ResMedRMD

——

4D Molecular TherapeuticsFDMT

——

MannkindMNKD

——

Other financials

Income statement

See full

Revenue$20.6M-8.7%

Gross profit$16.0M-1.8%

Operating income-$13.0M+11.0%

Net income-$13.7M+5.5%

EPS (diluted)-$0.33+8.3%

Balance sheet

See full

Cash & equivalents$61.0M-2.4%

Total debt$56.3M-1.2%

Total equity$45.8M-41.1%

Total assets$120.0M-20.4%

Cash flow

See full

Operating cash flow-$10.1M+23.6%

CapEx$9.0K-97.0%

Free cash flow-$10.1M+25.3%

Valuation

See full

Market cap$54.91M-43.7%

Enterprise value$50.17M-39.2%

P/S0.6×-0.5×

Profitability

See full

Gross margin75.5%+2.0pp

Operating margin-58.8%-5.8pp

Net margin-60.1%-4.4pp

FCF margin-33.2%-4.4pp

Returns & leverage

See full

Return on equity-86.2%+62.6pp

Debt / equity1.2×+0.5×

Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulmonx Corporation's accrued liabilities, current?: Pulmonx Corporation (LUNG) reported accrued liabilities, current of $13.73M in Q1 2026.
How has Pulmonx Corporation's accrued liabilities, current changed year-over-year?: Pulmonx Corporation's accrued liabilities, current increased by 18.9% year-over-year, from $11.55M to $13.73M.
What is the long-term trend for Pulmonx Corporation's accrued liabilities, current?: Over 5 years (2020 to 2025), Pulmonx Corporation's accrued liabilities, current has grown at a 11.0% compound annual growth rate (CAGR), from $8.65M to $14.56M.